Related Experiment Video
Updated: Jun 6, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Pharmacogenetics of antidepressant response
Robert Keers1, Katherine J Aitchison
1MRC SGDP Centre, Institute of Psychiatry at King's College London, 16 De Crespigny Park, Denmark Hill, London, SE5 8AF, UK. robert.keers@kcl.ac.uk
Expert Review of Neurotherapeutics
|December 17, 2010
Summary
Genetic variations influence antidepressant response, but predicting outcomes remains challenging due to small effect sizes and study heterogeneity. Future research needs standardized methods and intermediate phenotypes for robust genetic predictors.
Area of Science:
- Pharmacogenetics
- Neuroscience
- Genetics
Background:
- Individual responses to antidepressants vary significantly.
- Genetic factors are suggested by family and twin studies to contribute to these response differences.
- Pharmacogenetic research aims to identify genetic variants influencing antidepressant efficacy and predict treatment outcomes.
Purpose of the Study:
- To identify genetic variants associated with antidepressant response.
- To understand the mechanisms of action for antidepressant pharmacotherapies.
- To explore novel genetic candidates for predicting antidepressant treatment outcomes.
Main Methods:
- Investigated genes involved in antidepressant pharmacokinetics and pharmacodynamics.
- Employed hypothesis-free approaches to discover novel genetic predictors.
- Acknowledged limitations due to small effect sizes and study heterogeneity.
Main Results:
- Some implicated genes showed predictive value for antidepressant response, but replication has been inconsistent.
- Novel candidates were identified through hypothesis-free methods, but results were modest.
- Treatment outcome appears to be influenced by multiple genetic variants with small individual effects.
Conclusions:
- Robust genetic predictors for antidepressant response are hindered by small effect sizes and study heterogeneity.
- Standardized methodologies are crucial for future pharmacogenetic studies to enable direct comparison of findings.
- Utilizing intermediate phenotypes, such as neurogenesis, may offer a closer reflection of antidepressant mechanisms and improve predictive power.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...